№ lp_1_2_45084
File format: docx Character count: 41233 File size: 97 KB
Comprehensive regulatory assessment including quality, non-clinical, clinical, and pharmacovigilance aspects, addressing questions, inspections, and risk management for a generic or hybrid medicinal product submission.
Note: Year
Region / city: Amsterdam
Type of document: Assessment report
Committee / organization: Committee for Medicinal Products for Human Use (CHMP), Pharmacovigilance Risk Assessment Committee (PRAC)
Procedure number: EMEA/H/C/
Rapporteurs: CHMP Rapporteur, PRAC Rapporteur
Product type: Generic/hybrid medicinal product
Confidential information included: Yes / No
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Rapporteur day 80 critical assessment report (Article 10.1 or 10.3) Non clinical & clinical aspects – generic/hybrid medicinal products
Note: Year
CHMP assessment report template and instructions for initial marketing authorisation and EUM4All procedures
Organisation: European Medicines Agency
Committee: Committee for Medicinal Products for Human Use
Document type: Assessment report template and procedural guidance
Procedure scope: Initial marketing authorisation and EUM4All applications
Geographical scope: European Union
Language variant: British English
Intended contributors: Rapporteurs, Co-Rapporteurs, PRAC Rapporteurs, EMA Procedure Assistants
Regulatory framework: EU medicines regulatory procedure
Document status: Living document updated across procedural milestones
Source type: Regulatory guidance and internal procedural template
Request for Extension of Clock Stop for Submission of Responses to CHMP Questions
Year: 2023
Region / City: Amsterdam
Subject: Request for extension of clock stop duration in the centralized marketing authorization process
Document Type: Request template
Organization / Institution: European Medicines Agency
Author: EMA
Target Audience: Marketing Authorization Holders, Applicants
Period of Validity: N/A
Approval Date: N/A
Date of Changes: N/A
CHMP briefing document template
Year: 2026
Region / City: EU
Theme: Regulatory Affairs, Pharmaceuticals
Document Type: Template
Organization: European Medicines Agency
Author: European Medicines Agency
Target Audience: Pharmaceutical companies, regulatory affairs professionals
Validity Period: Not specified
Approval Date: Not specified
Modification Date: Not specified
Topics: EMEAHC generichybrid CHMP